Skip to content

Is Growth Hormone FDA Approved? Understanding its Medical and Illegal Uses

2 min read

Since first approving recombinant human growth hormone in 1985 for pediatric growth hormone deficiency, the FDA has expanded its list of approved indications. So, is growth hormone FDA approved? Yes, but only for a specific list of diagnosed medical conditions, and its distribution for any other use is illegal.

Quick Summary

Growth hormone (somatropin) is FDA-approved for specific pediatric and adult conditions, like growth hormone deficiency. Its distribution for unapproved purposes, including anti-aging or athletic enhancement, is a federal offense.

Key Points

  • FDA Approval is Conditional: Recombinant human growth hormone (somatropin) is FDA-approved for specific medical conditions in children and adults, not for general anti-aging, bodybuilding, or performance enhancement.

  • Illegal for Unapproved Use: The distribution and possession of HGH for unapproved purposes is explicitly prohibited by federal law and can be prosecuted as a felony.

  • Mechanism is IGF-1 Dependent: GH exerts its most significant growth-promoting effects indirectly by stimulating the liver to produce insulin-like growth factor-1 (IGF-1).

  • Serious Side Effects Exist: Potential adverse effects include increased intracranial pressure, fluid retention, carpal tunnel syndrome, and an increased risk of diabetes and certain cancers.

  • Diverse Formulations Available: Several FDA-approved brands of somatropin exist, including both daily and newer, long-acting once-weekly formulations designed to improve patient adherence.

  • Requires Medical Supervision: Due to the associated risks and the need for proper diagnosis, HGH therapy must be administered under the strict supervision of a qualified physician.

In This Article

FDA-Approved Medical Indications for Growth Hormone

Recombinant human growth hormone, or somatropin, is a synthetic protein similar to natural growth hormone. The FDA has approved its use for a limited number of specific medical conditions in both children and adults, based on clinical trials. A confirmed diagnosis for one of the approved conditions is necessary before starting therapy.

Approved Pediatric Indications:

  • Growth Hormone Deficiency (GHD)
  • Chronic Renal Insufficiency
  • Noonan Syndrome
  • Prader-Willi Syndrome (PWS)
  • Small for Gestational Age (SGA)
  • Idiopathic Short Stature (ISS)
  • Turner Syndrome (TS)
  • SHOX Deficiency

Approved Adult Indications:

  • Adult Growth Hormone Deficiency (AGHD)
  • HIV-associated Cachexia
  • Short Bowel Syndrome

The Pharmacology and Mechanism of Action

Growth hormone (GH) works through direct and indirect mechanisms, primarily via insulin-like growth factor-1 (IGF-1). GH is released by the anterior pituitary, controlled by hypothalamic hormones. It directly affects fat cells and indirectly stimulates IGF-1 production in the liver and other tissues, promoting bone growth and protein synthesis.

Illegal and Unapproved Uses of Growth Hormone

Human growth hormone (HGH) is often misused for unapproved purposes, which is illegal and risky. Federal law prohibits HGH distribution for unapproved uses, classifying it as a five-year felony.

Common Illicit Uses:

  • Anti-aging: Despite misconceptions, HGH has not been proven to reverse aging and carries risks.
  • Athletic Enhancement: Athletes and bodybuilders use HGH to increase muscle mass, but its effect on strength is unproven and potentially negative. It is a banned substance in major sports.

Potential Risks and Side Effects

Prescribed GH therapy has potential side effects.

Common Adverse Reactions:

  • Injection site reactions
  • Joint and muscle pain
  • Fluid retention
  • Carpal tunnel syndrome

Serious FDA Warnings and Risks:

  • Increased Intracranial Pressure
  • Impaired Glucose Tolerance and Diabetes
  • Increased Mortality in critically ill patients
  • Cancer risk
  • Slipped Capital Femoral Epiphysis in children
  • Worsening of Scoliosis in pediatric patients

Comparing Different FDA-Approved Growth Hormone Products

Multiple FDA-approved somatropin brands exist, differing in formulation, administration frequency, and devices. Some offer weekly injections for better adherence.

Feature Once-Daily Somatropin (e.g., Genotropin, Norditropin, Humatrope) Once-Weekly Somatrogon (Ngenla) or Somapacitan (Sogroya)
Injection Frequency Daily injection Weekly injection
Mechanism Standard recombinant human GH Longer-acting modified versions
Approved Indications (Examples) Broad range of pediatric and adult conditions Specific pediatric and adult GHD indications
Benefit Long-established safety and efficacy Reduced treatment burden
Potential Drawback Risk of poor adherence Newer to market, long-term safety under surveillance

Conclusion

Growth hormone is FDA approved for specific medical diagnoses, requiring strict medical oversight. Unapproved uses like anti-aging or athletic enhancement are illegal and carry significant health risks and legal consequences. Safe and effective use requires understanding the strict guidelines for those who genuinely need it. Consulting reliable medical sources like the FDA is recommended for more information.

Visit the official FDA website for more information on approved drug products.

Frequently Asked Questions

No, it is illegal to use growth hormone for purposes not approved by the FDA, such as bodybuilding, athletic enhancement, or anti-aging. Distribution and possession with intent to distribute for these unapproved uses is a federal felony.

The generic name for recombinant human growth hormone is somatropin. Many brands, including Genotropin, Norditropin, and Humatrope, are available under this generic name.

No, growth hormone is a peptide hormone that is inactivated during digestion. It must be administered via injection to be effective. Products marketed as HGH pills are often ineffective or may contain other unverified ingredients.

Approved pediatric uses include growth hormone deficiency, Prader-Willi Syndrome, Turner Syndrome, chronic kidney disease, and idiopathic short stature.

Common side effects include injection site reactions, joint and muscle pain, fluid retention (edema), and carpal tunnel syndrome.

Yes, the FDA has approved once-weekly growth hormone formulations, such as Ngenla (somatrogon) and Sogroya (somapacitan), for specific pediatric and adult conditions.

FDA-approved HGH (somatropin) is a legally prescribed medication for specific medical conditions under strict medical supervision. The kind abused for performance enhancement is obtained illegally, used without medical oversight, and may carry unverified ingredients and dosages.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.